Evaluation of four commercial systems for the diagnosis of epstein-barr virus primary infections

Clinical and Vaccine Immunology

Volumn 18, Issue 3, 2011, Pages 444-448

  De Ory, Fernando ^a   Guisasola, María Eulalia ^a   Sanz, Juan Carlos ^b   García Bermejo, Isabel ^c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Laboratorio de Salud Pública de la Comunidad de Madrid ^*  (Spain)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EVALUATION; HUMAN; IMMUNOCHEMISTRY; IMMUNOFILTRATION; IMMUNOFLUORESCENCE TEST; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS CAPSID;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CLINICAL LABORATORY TECHNIQUES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIROLOGY;

EID: 79952553854     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00486-10     Document Type: Article

References (13)

1. Balachandran, N., D. E. Oba, and L. M. Hutt-Fletcher. 1987. Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. J. Virol. 61:1125-1135.
2. Berth, M., and E. Bosmans. 2010. Comparison of three automated immunoassay methods for the measurement of Epstein-Barr virus-specific immunoglobulin M. Clin. Vaccine Immunol. 17:559-563.
3. Bravo, D., et al. 2009. Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients. Clin. Vaccine Immunol. 16:885-888.
4. De Ory, F., J. Antonaya, M. V. Fernández, J. M. Echevarría, and A. de la Loma. 1993. Comparison of diagnostic criteria for Epstein Barr virus infection in children. Serodiagn. Immunother. Infect. Dis. 1:46-48.
5. De Ory Manchón, F. 1994. Ph.D. thesis. Universidad Complutense, Madrid, Spain.
6. De Paschale, M., et al. 2009. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern. J. Med. Virol. 81:325-331.
7. Evans, A. S. 1978. Infectious mononucleosis and related syndromes. Am. J. Med. Sci. 276:325-339.
8. García, T., N. Tormo, C. Gimeno, and D. Navarro. 2008. Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile. J. Infect. 57:351-353.
9. Haukenes, G., et al. 1994. Viral antibodies in infectious mononucleosis. FEMS Immunol. Med. Microbiol. 8:219-224.
10. Hurt, C., and D. Tammaro. 2007. Diagnostic evaluation of mononucleosis like illnesses. Am. J. Med. 120:911.e1-911.e8.
11. Miendje Deyi, Y., P. Goubau, and M. Bodéus. 2000. False positive IgM antibody assays for cytomegalovirus in patients with acute Epstein Barr virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 19:557-560.
12. Nikoskelainen, J., J. Keikola, and E. Klemola. 1974. IgM antibodies specific for Epstein Barr virus in infectious mononucleosis without heterophil antibodies. BMJ 2:72-75.
13. Sumaya, C. V., and Y. Ench. 1985. Epstein Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral specific responses. Pediatrics 75:1011-1019.